CUSIP 98937L105COMZBIOQ4 2025
17 filings · latest Feb 5, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Fmr LLC | 7.70M | $279.74M |
| 2 | Sr One Capital Management, LP | 5.04M | $182.92M |
| 3 | Enavate Sciences Gp, LLC | 3.92M | $142.30M |
| 4 | Nea Management Company, LLC | 3.52M | $127.93M |
| 5 | Federated Hermes, Inc. | 2.72M | $98.60M |
| 6 | Fairmount Funds Management LLC | 2.21M | $80.21M |
| 7 | Nvp Associates, LLC | 1.84M | $66.76M |
| 8 | Blackrock, Inc. | 1.77M | $64.18M |
| 9 |
| 4 | Oct 15, 2025 | Innocare Pharma Inc. | 13G | 9.4% | 5.00M | SEC |
| 5 | Oct 14, 2025 | Enavate Sciences Gp, LLC | 13D/A | 7.3% | — | SEC |
| 6 | Oct 14, 2025 | Sr One Capital Management, LLC | 13D/A | 9.4% | — | SEC |
| 7 | Oct 14, 2025 | Longitude Capital Partners IV, LLC | 13D/A | 4.9% | — | SEC |
| 8 | Oct 9, 2025 | Leon O. Moulder, Jr. | 13D/A | 4.8% | — | SEC |
| 9 | Sep 8, 2025 | Fmr LLC | 13G/A | 11.0% | 4.64M | SEC |
| 10 | Aug 6, 2025 | Fmr LLC | 13G/A | 7.9% | 3.32M | SEC |
See the full Schedule 13D/13G history for Zenas Biopharma Inc.
Unlock full history| Vanguard Group Inc |
| 1.45M |
| $52.76M |
| 10 | Novo Holdings A/S | 1.45M | $52.65M |